A share price of Conmed Corp [CNMD] is currently trading at $57.19, up 16.45%. An important factor to consider is whether the stock is rising or falling in short-term value. The CNMD shares have gain 12.14% over the last week, with a monthly amount drifted -3.72%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Conmed Corp [NYSE: CNMD] stock has seen the most recent analyst activity on April 28, 2025, when Stifel downgraded its rating to a Hold but kept the price target unchanged to $55 for it. Previously, JP Morgan downgraded its rating to Neutral on February 06, 2025, and dropped its price target to $70. On February 01, 2024, Needham reiterated its Buy rating and revised its price target to $129 on the stock. CL King started tracking the stock assigning a Buy rating and suggested a price target of $140 on May 22, 2023. KeyBanc Capital Markets upgraded its rating to a Overweight but $124 remained the price target by the analyst firm on March 27, 2023. Wells Fargo started tracking with a Equal Weight rating for this stock on March 21, 2023, and assigned it a price target of $96. In a note dated October 12, 2022, Jefferies initiated an Hold rating and provided a target price of $85 on this stock.
Conmed Corp experienced fluctuations in its stock price throughout the past year between $46.00 and $78.58. Currently, Wall Street analysts expect the stock to reach $96 within the next 12 months. Conmed Corp [NYSE: CNMD] shares were valued at $57.19 at the most recent close of the market. An investor can expect a potential return of 67.86% based on the average CNMD price forecast.
Analyzing the CNMD fundamentals
Trailing Twelve Months sales for Conmed Corp [NYSE:CNMD] were 1.30B which represents 5.55% growth. Gross Profit Margin for this corporation currently stands at 0.55% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.11%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.13 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.91.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 54.54 points at the first support level, and at 51.89 for the second support level. However, for the 1st resistance point, the stock is sitting at 59.91, and for the 2nd resistance point, it is at 62.64.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Conmed Corp [NYSE:CNMD] is 2.30. On the other hand, the Quick Ratio is 1.05, and the Cash Ratio is 0.13. Considering the valuation of this stock, the price to sales ratio is 1.36, the price to book ratio is 1.84 and price to earnings (TTM) ratio is 13.45.
Transactions by insiders
Recent insider trading involved Hartman Curt R, Former Officer, that happened on Feb 14 ’25 when 2905.0 shares were purchased. Chief Information Officer, Glaze Richard completed a deal on Feb 11 ’25 to sell 257.0 shares. Meanwhile, Former Officer Hartman Curt R bought 4986.0 shares on Feb 13 ’25.
